Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
2
×
fda
life sciences
national
national blog main
national top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san francisco blog main
san francisco top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
aspire capital fund
astrazeneca
auris health
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
david mcnally
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
What
plans
2
×
acquisitions
announced
bio
cash
ceo
clearance
collabs
company
covid
crunch
daniel
deal
didn’t
end
fda
gilead
gilead’s
goal
help
introduce
ipo
medical
medical’s
medicines
meet
month
needs
o’day
robot
robotic
roundup
sciences
stalls
submitting
surgical
titan
transformative
years
Language
unset
Current search:
plans
×
biotech
×
" raleigh-durham blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA